269 related articles for article (PubMed ID: 31212299)
1. Decreased Circulating Levels of Asprosin in Obese Children.
Long W; Xie X; Du C; Zhao Y; Zhang C; Zhan D; Li Z; Ning Q; Luo X
Horm Res Paediatr; 2019; 91(4):271-277. PubMed ID: 31212299
[TBL] [Abstract][Full Text] [Related]
2. Serum Asprosin Concentrations Are Increased and Associated with Insulin Resistance in Children with Obesity.
Wang M; Yin C; Wang L; Liu Y; Li H; Li M; Yi X; Xiao Y
Ann Nutr Metab; 2019; 75(4):205-212. PubMed ID: 31775140
[TBL] [Abstract][Full Text] [Related]
3. Asprosin serum levels and glucose homeostasis in children with obesity.
Corica D; Aversa T; Currò M; Tropeano A; Pepe G; Alibrandi A; Ientile R; Wasniewska M
Cytokine; 2021 Jun; 142():155477. PubMed ID: 33662891
[TBL] [Abstract][Full Text] [Related]
4. Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride.
Zhang L; Chen C; Zhou N; Fu Y; Cheng X
Clin Chim Acta; 2019 Feb; 489():183-188. PubMed ID: 29104036
[TBL] [Abstract][Full Text] [Related]
5. Increased serum circulating asprosin levels in children with obesity.
Sünnetçi Silistre E; Hatipoğl HU
Pediatr Int; 2020 Apr; 62(4):467-476. PubMed ID: 32003085
[TBL] [Abstract][Full Text] [Related]
6. Plasma Asprosin Concentrations Are Increased in Individuals with Glucose Dysregulation and Correlated with Insulin Resistance and First-Phase Insulin Secretion.
Wang Y; Qu H; Xiong X; Qiu Y; Liao Y; Chen Y; Zheng Y; Zheng H
Mediators Inflamm; 2018; 2018():9471583. PubMed ID: 29743813
[TBL] [Abstract][Full Text] [Related]
7. Plasma Asprosin Levels Are Associated with Glucose Metabolism, Lipid, and Sex Hormone Profiles in Females with Metabolic-Related Diseases.
Li X; Liao M; Shen R; Zhang L; Hu H; Wu J; Wang X; Qu H; Guo S; Long M; Zheng H
Mediators Inflamm; 2018; 2018():7375294. PubMed ID: 30524197
[TBL] [Abstract][Full Text] [Related]
8. Serum asprosin levels and bariatric surgery outcomes in obese adults.
Wang CY; Lin TA; Liu KH; Liao CH; Liu YY; Wu VC; Wen MS; Yeh TS
Int J Obes (Lond); 2019 May; 43(5):1019-1025. PubMed ID: 30459402
[TBL] [Abstract][Full Text] [Related]
9. Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome.
Alan M; Gurlek B; Yilmaz A; Aksit M; Aslanipour B; Gulhan I; Mehmet C; Taner CE
Gynecol Endocrinol; 2019 Mar; 35(3):220-223. PubMed ID: 30325247
[TBL] [Abstract][Full Text] [Related]
10. Meal-Related Asprosin Serum Levels Are Affected by Insulin Resistance and Impaired Fasting Glucose in Children With Obesity.
Corica D; Pepe G; Aversa T; Currò M; Curatola S; Li Pomi A; Alibrandi A; Ientile R; Wasniewska M
Front Endocrinol (Lausanne); 2021; 12():805700. PubMed ID: 35069452
[TBL] [Abstract][Full Text] [Related]
11. Different spexin level in obese vs normal weight children and its relationship with obesity related risk factors.
Behrooz M; Vaghef-Mehrabany E; Ostadrahimi A
Nutr Metab Cardiovasc Dis; 2020 Apr; 30(4):674-682. PubMed ID: 32139252
[TBL] [Abstract][Full Text] [Related]
12. The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients.
Chang CL; Huang SY; Hsu YC; Chin TH; Soong YK
Sci Rep; 2019 Apr; 9(1):6447. PubMed ID: 31015585
[TBL] [Abstract][Full Text] [Related]
13. Increased asprosin is associated with non-alcoholic fatty liver disease in children with obesity.
Liu LJ; Kang YR; Xiao YF
World J Pediatr; 2021 Aug; 17(4):394-399. PubMed ID: 34370215
[TBL] [Abstract][Full Text] [Related]
14. Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: Comprehensive review of preclinical and clinical evidence.
Shabir K; Brown JE; Afzal I; Gharanei S; Weickert MO; Barber TM; Kyrou I; Randeva HS
Cytokine Growth Factor Rev; 2021 Aug; 60():120-132. PubMed ID: 34108103
[TBL] [Abstract][Full Text] [Related]
15. Meteorin-like Protein and Asprosin Levels in Children and Adolescents with Obesity and Their Relationship with Insulin Resistance and Metabolic Syndrome.
Moradi N; Fadaei R; Roozbehkia M; Nourbakhsh M; Nourbakhsh M; Razzaghy-Azar M; Larijani B
Lab Med; 2023 Sep; 54(5):457-463. PubMed ID: 36762837
[TBL] [Abstract][Full Text] [Related]
16. Asprosin in umbilical cord of newborns and maternal blood of gestational diabetes, preeclampsia, severe preeclampsia, intrauterine growth retardation and macrosemic fetus.
Baykus Y; Yavuzkir S; Ustebay S; Ugur K; Deniz R; Aydin S
Peptides; 2019 Oct; 120():170132. PubMed ID: 31400492
[TBL] [Abstract][Full Text] [Related]
17. Asprosin, a Fasting-Induced Glucogenic Protein Hormone.
Romere C; Duerrschmid C; Bournat J; Constable P; Jain M; Xia F; Saha PK; Del Solar M; Zhu B; York B; Sarkar P; Rendon DA; Gaber MW; LeMaire SA; Coselli JS; Milewicz DM; Sutton VR; Butte NF; Moore DD; Chopra AR
Cell; 2016 Apr; 165(3):566-79. PubMed ID: 27087445
[TBL] [Abstract][Full Text] [Related]
18. Effects of GLP-1 receptor agonists on asprosin levels in normal weight or overweight/obesity patients with type 2 diabetes mellitus.
Dai C; Zhu W
Medicine (Baltimore); 2022 Oct; 101(43):e31334. PubMed ID: 36316938
[TBL] [Abstract][Full Text] [Related]
19. Serum Asprosin Concentrations in Children with Prader-Willi Syndrome: Correlations with Metabolic Parameters.
Alsaif M; Field CJ; Colin-Ramirez E; Prado CM; Haqq AM
J Clin Med; 2022 Apr; 11(8):. PubMed ID: 35456360
[TBL] [Abstract][Full Text] [Related]
20. Energy Regulation Mechanism and Therapeutic Potential of Asprosin.
Hoffmann JG; Xie W; Chopra AR
Diabetes; 2020 Apr; 69(4):559-566. PubMed ID: 32198197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
